Leishmania major and Leishmania tropica : I the in vitro effects of an immunomodulator, S2-Complex

This study was undertaken to try to determine the possible anti-leishmanial activity of S2-Complex, an organic complex of copper chloride, ascorbic acid, and nicotinamide. The promastigotes, axenic amastigotes, and intracellular amastigotes of both Leishmania major and Leishmania tropica were incuba...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Experimental parasitology 2005-09, Vol.111 (1), p.47-54
Hauptverfasser: AL-MULLA HUMMADI, Yassir M, NAJIM, Rafid A, AL-BASHIR, Nada M
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 54
container_issue 1
container_start_page 47
container_title Experimental parasitology
container_volume 111
creator AL-MULLA HUMMADI, Yassir M
NAJIM, Rafid A
AL-BASHIR, Nada M
description This study was undertaken to try to determine the possible anti-leishmanial activity of S2-Complex, an organic complex of copper chloride, ascorbic acid, and nicotinamide. The promastigotes, axenic amastigotes, and intracellular amastigotes of both Leishmania major and Leishmania tropica were incubated with different concentrations of S2-Complex. The EC50 for each form was calculated. Results show that all forms of the parasites were dose dependently inhibited by S2-Complex. The promastigotes of both parasites were the most resistant with highest EC50 followed by axenic amastigotes. While intracellular amastigotes were the most sensitive with the lowest EC50. These results indicate that S2-Complex has a direct anti-leishmanial effect. When mice were treated with S2-Complex or BCG for four days before harvesting the macrophages, and the macrophages infected with both L. major and L. tropica, they showed increased phagocytosis and increased parasite killing. The results of S2-Complex were not statistically different from the immunomodulating agent BCG. These results indicate that S2-Complex has an immunomodulating effect in addition to the direct anti-leishmanial effect.
doi_str_mv 10.1016/j.exppara.2005.04.007
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68427606</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>68427606</sourcerecordid><originalsourceid>FETCH-LOGICAL-c252t-7368e1f87de738f9e9a9a5f1177b50e681739d4014cd5c01e2f823f93ea25c403</originalsourceid><addsrcrecordid>eNpNkF2L1TAQhoMo7nH1Jyi50StbJ2nSJN7JwY-FA16o1yEnnbA5NE1NWln_vV22sF4NvDzvDPMQ8ppBy4D1Hy4t3s2zK67lALIF0QKoJ-TAwEDDhTBPyQGAiUZoI67Ii1ovAKAZF8_JFZNGAdf9gZxPGOttclN0NLlLLtRNA_0vXEqeo3f0I72hyy3SONE_cQsphoB-qTSHrUJjSuuUUx7W0S25vKc_eHPMaR7x7iV5FtxY8dU-r8mvL59_Hr81p-9fb46fTo3nki-N6nqNLGg1oOp0MGiccTIwptRZAvaaqc4MYnvJD9IDQx4074Lp0HHpBXTX5N3D3rnk3yvWxaZYPY6jmzCv1fZacNVDv4HyAfQl11ow2LnE5Mpfy8Dey7UXu8u193ItCLvJ3Xpv9gPrOeHw2NptbsDbHXDVuzEUN_lYHzkFnQTOu393T4Qw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>68427606</pqid></control><display><type>article</type><title>Leishmania major and Leishmania tropica : I the in vitro effects of an immunomodulator, S2-Complex</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>AL-MULLA HUMMADI, Yassir M ; NAJIM, Rafid A ; AL-BASHIR, Nada M</creator><creatorcontrib>AL-MULLA HUMMADI, Yassir M ; NAJIM, Rafid A ; AL-BASHIR, Nada M</creatorcontrib><description>This study was undertaken to try to determine the possible anti-leishmanial activity of S2-Complex, an organic complex of copper chloride, ascorbic acid, and nicotinamide. The promastigotes, axenic amastigotes, and intracellular amastigotes of both Leishmania major and Leishmania tropica were incubated with different concentrations of S2-Complex. The EC50 for each form was calculated. Results show that all forms of the parasites were dose dependently inhibited by S2-Complex. The promastigotes of both parasites were the most resistant with highest EC50 followed by axenic amastigotes. While intracellular amastigotes were the most sensitive with the lowest EC50. These results indicate that S2-Complex has a direct anti-leishmanial effect. When mice were treated with S2-Complex or BCG for four days before harvesting the macrophages, and the macrophages infected with both L. major and L. tropica, they showed increased phagocytosis and increased parasite killing. The results of S2-Complex were not statistically different from the immunomodulating agent BCG. These results indicate that S2-Complex has an immunomodulating effect in addition to the direct anti-leishmanial effect.</description><identifier>ISSN: 0014-4894</identifier><identifier>EISSN: 1090-2449</identifier><identifier>DOI: 10.1016/j.exppara.2005.04.007</identifier><identifier>PMID: 15970286</identifier><identifier>CODEN: EXPAAA</identifier><language>eng</language><publisher>San Diego, CA: Elsevier</publisher><subject><![CDATA[Animals ; Ascorbic Acid - administration & dosage ; Ascorbic Acid - pharmacology ; BCG Vaccine - administration & dosage ; BCG Vaccine - immunology ; BCG Vaccine - pharmacology ; Biological and medical sciences ; Copper - administration & dosage ; Copper - pharmacology ; Culture Media ; Drug Combinations ; Fundamental and applied biological sciences. Psychology ; Immunologic Factors - administration & dosage ; Immunologic Factors - pharmacology ; Injections, Intraperitoneal ; Leishmania major - drug effects ; Leishmania tropica - drug effects ; Life cycle. Host-agent relationship. Pathogenesis ; Macrophages, Peritoneal - drug effects ; Mice ; Mice, Inbred BALB C ; Niacinamide - administration & dosage ; Niacinamide - pharmacology ; Protozoa ; Starch - administration & dosage]]></subject><ispartof>Experimental parasitology, 2005-09, Vol.111 (1), p.47-54</ispartof><rights>2005 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c252t-7368e1f87de738f9e9a9a5f1177b50e681739d4014cd5c01e2f823f93ea25c403</citedby><cites>FETCH-LOGICAL-c252t-7368e1f87de738f9e9a9a5f1177b50e681739d4014cd5c01e2f823f93ea25c403</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=17035022$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15970286$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>AL-MULLA HUMMADI, Yassir M</creatorcontrib><creatorcontrib>NAJIM, Rafid A</creatorcontrib><creatorcontrib>AL-BASHIR, Nada M</creatorcontrib><title>Leishmania major and Leishmania tropica : I the in vitro effects of an immunomodulator, S2-Complex</title><title>Experimental parasitology</title><addtitle>Exp Parasitol</addtitle><description>This study was undertaken to try to determine the possible anti-leishmanial activity of S2-Complex, an organic complex of copper chloride, ascorbic acid, and nicotinamide. The promastigotes, axenic amastigotes, and intracellular amastigotes of both Leishmania major and Leishmania tropica were incubated with different concentrations of S2-Complex. The EC50 for each form was calculated. Results show that all forms of the parasites were dose dependently inhibited by S2-Complex. The promastigotes of both parasites were the most resistant with highest EC50 followed by axenic amastigotes. While intracellular amastigotes were the most sensitive with the lowest EC50. These results indicate that S2-Complex has a direct anti-leishmanial effect. When mice were treated with S2-Complex or BCG for four days before harvesting the macrophages, and the macrophages infected with both L. major and L. tropica, they showed increased phagocytosis and increased parasite killing. The results of S2-Complex were not statistically different from the immunomodulating agent BCG. These results indicate that S2-Complex has an immunomodulating effect in addition to the direct anti-leishmanial effect.</description><subject>Animals</subject><subject>Ascorbic Acid - administration &amp; dosage</subject><subject>Ascorbic Acid - pharmacology</subject><subject>BCG Vaccine - administration &amp; dosage</subject><subject>BCG Vaccine - immunology</subject><subject>BCG Vaccine - pharmacology</subject><subject>Biological and medical sciences</subject><subject>Copper - administration &amp; dosage</subject><subject>Copper - pharmacology</subject><subject>Culture Media</subject><subject>Drug Combinations</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Immunologic Factors - administration &amp; dosage</subject><subject>Immunologic Factors - pharmacology</subject><subject>Injections, Intraperitoneal</subject><subject>Leishmania major - drug effects</subject><subject>Leishmania tropica - drug effects</subject><subject>Life cycle. Host-agent relationship. Pathogenesis</subject><subject>Macrophages, Peritoneal - drug effects</subject><subject>Mice</subject><subject>Mice, Inbred BALB C</subject><subject>Niacinamide - administration &amp; dosage</subject><subject>Niacinamide - pharmacology</subject><subject>Protozoa</subject><subject>Starch - administration &amp; dosage</subject><issn>0014-4894</issn><issn>1090-2449</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpNkF2L1TAQhoMo7nH1Jyi50StbJ2nSJN7JwY-FA16o1yEnnbA5NE1NWln_vV22sF4NvDzvDPMQ8ppBy4D1Hy4t3s2zK67lALIF0QKoJ-TAwEDDhTBPyQGAiUZoI67Ii1ovAKAZF8_JFZNGAdf9gZxPGOttclN0NLlLLtRNA_0vXEqeo3f0I72hyy3SONE_cQsphoB-qTSHrUJjSuuUUx7W0S25vKc_eHPMaR7x7iV5FtxY8dU-r8mvL59_Hr81p-9fb46fTo3nki-N6nqNLGg1oOp0MGiccTIwptRZAvaaqc4MYnvJD9IDQx4074Lp0HHpBXTX5N3D3rnk3yvWxaZYPY6jmzCv1fZacNVDv4HyAfQl11ow2LnE5Mpfy8Dey7UXu8u193ItCLvJ3Xpv9gPrOeHw2NptbsDbHXDVuzEUN_lYHzkFnQTOu393T4Qw</recordid><startdate>200509</startdate><enddate>200509</enddate><creator>AL-MULLA HUMMADI, Yassir M</creator><creator>NAJIM, Rafid A</creator><creator>AL-BASHIR, Nada M</creator><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200509</creationdate><title>Leishmania major and Leishmania tropica : I the in vitro effects of an immunomodulator, S2-Complex</title><author>AL-MULLA HUMMADI, Yassir M ; NAJIM, Rafid A ; AL-BASHIR, Nada M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c252t-7368e1f87de738f9e9a9a5f1177b50e681739d4014cd5c01e2f823f93ea25c403</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Animals</topic><topic>Ascorbic Acid - administration &amp; dosage</topic><topic>Ascorbic Acid - pharmacology</topic><topic>BCG Vaccine - administration &amp; dosage</topic><topic>BCG Vaccine - immunology</topic><topic>BCG Vaccine - pharmacology</topic><topic>Biological and medical sciences</topic><topic>Copper - administration &amp; dosage</topic><topic>Copper - pharmacology</topic><topic>Culture Media</topic><topic>Drug Combinations</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Immunologic Factors - administration &amp; dosage</topic><topic>Immunologic Factors - pharmacology</topic><topic>Injections, Intraperitoneal</topic><topic>Leishmania major - drug effects</topic><topic>Leishmania tropica - drug effects</topic><topic>Life cycle. Host-agent relationship. Pathogenesis</topic><topic>Macrophages, Peritoneal - drug effects</topic><topic>Mice</topic><topic>Mice, Inbred BALB C</topic><topic>Niacinamide - administration &amp; dosage</topic><topic>Niacinamide - pharmacology</topic><topic>Protozoa</topic><topic>Starch - administration &amp; dosage</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>AL-MULLA HUMMADI, Yassir M</creatorcontrib><creatorcontrib>NAJIM, Rafid A</creatorcontrib><creatorcontrib>AL-BASHIR, Nada M</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Experimental parasitology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>AL-MULLA HUMMADI, Yassir M</au><au>NAJIM, Rafid A</au><au>AL-BASHIR, Nada M</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Leishmania major and Leishmania tropica : I the in vitro effects of an immunomodulator, S2-Complex</atitle><jtitle>Experimental parasitology</jtitle><addtitle>Exp Parasitol</addtitle><date>2005-09</date><risdate>2005</risdate><volume>111</volume><issue>1</issue><spage>47</spage><epage>54</epage><pages>47-54</pages><issn>0014-4894</issn><eissn>1090-2449</eissn><coden>EXPAAA</coden><abstract>This study was undertaken to try to determine the possible anti-leishmanial activity of S2-Complex, an organic complex of copper chloride, ascorbic acid, and nicotinamide. The promastigotes, axenic amastigotes, and intracellular amastigotes of both Leishmania major and Leishmania tropica were incubated with different concentrations of S2-Complex. The EC50 for each form was calculated. Results show that all forms of the parasites were dose dependently inhibited by S2-Complex. The promastigotes of both parasites were the most resistant with highest EC50 followed by axenic amastigotes. While intracellular amastigotes were the most sensitive with the lowest EC50. These results indicate that S2-Complex has a direct anti-leishmanial effect. When mice were treated with S2-Complex or BCG for four days before harvesting the macrophages, and the macrophages infected with both L. major and L. tropica, they showed increased phagocytosis and increased parasite killing. The results of S2-Complex were not statistically different from the immunomodulating agent BCG. These results indicate that S2-Complex has an immunomodulating effect in addition to the direct anti-leishmanial effect.</abstract><cop>San Diego, CA</cop><pub>Elsevier</pub><pmid>15970286</pmid><doi>10.1016/j.exppara.2005.04.007</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0014-4894
ispartof Experimental parasitology, 2005-09, Vol.111 (1), p.47-54
issn 0014-4894
1090-2449
language eng
recordid cdi_proquest_miscellaneous_68427606
source MEDLINE; Access via ScienceDirect (Elsevier)
subjects Animals
Ascorbic Acid - administration & dosage
Ascorbic Acid - pharmacology
BCG Vaccine - administration & dosage
BCG Vaccine - immunology
BCG Vaccine - pharmacology
Biological and medical sciences
Copper - administration & dosage
Copper - pharmacology
Culture Media
Drug Combinations
Fundamental and applied biological sciences. Psychology
Immunologic Factors - administration & dosage
Immunologic Factors - pharmacology
Injections, Intraperitoneal
Leishmania major - drug effects
Leishmania tropica - drug effects
Life cycle. Host-agent relationship. Pathogenesis
Macrophages, Peritoneal - drug effects
Mice
Mice, Inbred BALB C
Niacinamide - administration & dosage
Niacinamide - pharmacology
Protozoa
Starch - administration & dosage
title Leishmania major and Leishmania tropica : I the in vitro effects of an immunomodulator, S2-Complex
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-20T10%3A19%3A28IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Leishmania%20major%20and%20Leishmania%20tropica%20:%20I%20the%20in%20vitro%20effects%20of%20an%20immunomodulator,%20S2-Complex&rft.jtitle=Experimental%20parasitology&rft.au=AL-MULLA%20HUMMADI,%20Yassir%20M&rft.date=2005-09&rft.volume=111&rft.issue=1&rft.spage=47&rft.epage=54&rft.pages=47-54&rft.issn=0014-4894&rft.eissn=1090-2449&rft.coden=EXPAAA&rft_id=info:doi/10.1016/j.exppara.2005.04.007&rft_dat=%3Cproquest_cross%3E68427606%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=68427606&rft_id=info:pmid/15970286&rfr_iscdi=true